Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,311 | -52,796 | -165,757 | -110,949 | -69,142 |
| Depreciation Amortization | 161 | 80 | 327 | 246 | 161 |
| Accounts receivable | -183 | -35 | -248 | N/A | N/A |
| Other Working Capital | 3,413 | -5,476 | 10,674 | 333 | -5,163 |
| Other Operating Activity | 12,361 | 5,874 | 19,663 | 13,668 | 8,628 |
| Operating Cash Flow | $-90,559 | $-52,353 | $-135,341 | $-96,702 | $-65,516 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | -139 | -139 | -139 |
| Investing Cash Flow | $-20 | $N/A | $-139 | $-139 | $-139 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 98,600 | 98,600 | 68,600 |
| Common Stock Issued | 25,165 | 24,915 | 283 | 233 | 185 |
| Other Financing Activity | -766 | -766 | -2,646 | -2,646 | -2,646 |
| Financing Cash Flow | $24,399 | $24,149 | $96,237 | $96,187 | $66,139 |
| Beginning Cash Position | 193,725 | 193,725 | 232,968 | 232,968 | 232,968 |
| End Cash Position | 127,545 | 165,521 | 193,725 | 232,314 | 233,452 |
| Net Cash Flow | $-66,180 | $-28,204 | $-39,243 | $-654 | $484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,559 | -52,353 | -135,341 | -96,702 | -65,516 |
| Capital Expenditure | -20 | N/A | -139 | -139 | -139 |
| Free Cash Flow | -90,579 | -52,353 | -135,480 | -96,841 | -65,655 |